Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease. Authors' reply

Affiliations

Editorial

Young-Seon Mederacke et al. Aliment Pharmacol Ther. 2020 Jul.

. 2020 Jul;52(2):391-392.

doi: 10.1111/apt.15873.

¹ Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.

No abstract available

Comment on

The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
Mederacke YS, Kirstein MM, Großhennig A, Marhenke S, Metzler F, Manns MP, Vogel A, Mederacke I. Mederacke YS, et al. Aliment Pharmacol Ther. 2020 Jun;51(11):1160-1168. doi: 10.1111/apt.15722. Epub 2020 Apr 22. Aliment Pharmacol Ther. 2020. PMID: 32323349
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease.
Huang JF, Chuang WL. Huang JF, et al. Aliment Pharmacol Ther. 2020 Jul;52(2):390-391. doi: 10.1111/apt.15788. Aliment Pharmacol Ther. 2020. PMID: 32592253 No abstract available.

1. Huang J-F, Chuang W-L. Editorial: PNPLA3 genotype and liver diseases - more than non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;52:390-391.
1. Mederacke Y-S, Kirstein MM, Großhennig A, et al. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020;51:1160-1168.
1. Valenti L, Al-Serri A, Daly AK, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1209-1217.
1. Krawczyk M, Grunhage F, Zimmer V, Lammert F. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol. 2011;55:299-306.
1. Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.